| PHARMING GRP EO-,01 |
| Niederlande |
| Gesundheit |
| NL0010391025 / A1H65A |
| PHGN (Frankfurt) |
| FRA:PHGN, ETR:PHGN, PHGN:GR |
| - |
| https://www.pharming.com/ |
|
Pharming Group N.V. is a global biopharmaceutical company specializing in the development and commercialization of innovative protein replacement therapies and precision medicines for rare, debilitati..
>Volltext.. |
| 967.24 Mio. EUR |
| 912.44 Mio. EUR |
| 333.56 Mio. EUR |
| 40.34 Mio. EUR |
| -0.04 Mio. EUR |
| - |
| 100.48 Mio. EUR |
| 126.77 Mio. EUR |
| 45.21 Mio. EUR |
| 1.55 |
| 24.21% |
| 99.75% |
| - |
| - |
| - |
| - |
| PHARMING |
| 13.03.26 |
|
||||
|